Biopharmaceutical firm Diffusion Pharmaceuticals Inc (NASDAQ:DFFN) was on the radars of many investors yesterday and surged by as much as 17%. There may not have been any news about the company yesterday but back on Monday the company announced that its Chief Executive Officer Robert Cobuzzi was going to be a presented at the Life Sciences Investors Forum.
The event is going to take place later on today and Cobuzzi is going to make the presentation by way of a webcast. The presentation from Cobuzzi is going to start at 11:30 a.m. Eastern Time.
It is likely that the rally in the stock may have been triggered in anticipation of the presentation that is going to be made by Cobuzzi and investors could consider keeping an eye on the Diffusion stock this morning.
However, that is not all. The company is also going to hold its Annual Meeting of Shareholders on Friday June 25, 2021 and the Diffusion shareholders are going to vote on a range of proposals at the meeting. It is another vital event for the company and is likely going to have an impact on the Diffusion’s business going forward. In light of these two upcoming events, the stock is expected to be in focus through the rest of the week.
On Wednesday, DFFN stock jumped by 16.70% to $0.82 with more than 2.41 million shares, compared to its average volume of 1.54 million shares. The stock has moved within a range of $0.7000 – 0.8200after opening the trade at $0.70. Over the past 52-week, the stock has been trading within a range of $0.6000 – 1.8500.